Uppsala University Hospital / Akademiska sjukhuset

Hospital


Location: Uppsala, Sweden (SE) SE

ISNI: 0000000123513333

ROR: https://ror.org/01apvbh93

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Quality indicators for breast reconstruction following cancer - an international Delphi consensus study supported by the European Society of Plastic, Reconstructive and Aesthetic Surgery (2025) Hansson E, Moellhoff N, Ahlstedt Karlsson S, Uusimäki A, Kaartinen I, Rosenkrantz Hölmich L, Zic R, et al. Journal article The LYMPH trial: comparing microsurgical with conservative treatment for chronic breast cancer-associated lymphoedema - study protocol of a pragmatic randomised international multicentre superiority trial (2025) Kappos EA, Haas Y, Schulz A, Peters F, Savanthrapadian S, Stoffel J, Katapodi MC, et al. Journal article Microsurgical versus complex physical decongestive therapy for chronic breast cancer-related lymphoedema (2025) Haas Y, Williams OP, Masia J, Pons G, Taylor EM, Katapodi MC, Staub D, et al. Journal article Emotion regulation-based internet-delivered cognitive behavioural therapy for premenstrual dysphoric disorder: study protocol for a randomised controlled trial in Sweden (2025) Hoppe JM, Weise C, Kleinstaeuber M, Skalkidou A, Vegelius J, Comasco E, Gröndal M, et al. Journal article Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell Transplantation (2025) Hall VG, Chiarello C, Remberger M, Kumar D, Pasic I, Kim DDH, Kumar R, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7) (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article, Erratum Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets (2024) Sandler Topelius N, Shokraneh F, Bahman M, Lahtinen J, Hassinen N, Airaksinen S, Verma S, et al. Journal article Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study. (2024) Pasic I, Moya TA, Remberger M, Chen C, Gerbitz A, Kim DDH, Kumar R, et al. Journal article Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry (2024) Brioli A, Lomaia E, Fabisch C, Sacha T, Klamova H, Morozova E, Golos A, et al. Journal article